At the 180-day follow-up , 54 % of the patients in the 33C group had died or had poor neurologic function according to the CPC , as compared with 52 % of patients in the 36C group ( risk ratio , 1.02 ; 95 % CI , 0.88 to 1.16 ; P = 0.78 ) .